Atezolizumab

Atezolizumab is a humanized monoclonal antibody directed at human programmed death-ligand 1 (PD-L1), a negative regulator of T-cell activity. Atezolizumab potentiates T-cell responses, including anti-tumour responses.

What can Sanquin do for you?

  • Measure drug levels of free drug in the serum using an validated ELISA.
  • Measure the immunogenicity of atezolizumab.
  • Provide assay reagents or co-develop novel testing strategies.
  • Folllowing ISO, FDA/EMA, RUO guidelines.

Enquire about our drug level and ADA assays by emailing us at [email protected].